VolitionRX (VNRX) Earnings Date & Reports

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis... Show more

Industry: #Medical Or Nursing Services

Get AI intraday signals

A.I. Advisor

published Earnings

VNRX is expected to report earnings to fall 35.88% to -62 cents per share on August 19

Q2'26

Est.

$-0.62

Q1'26

Missed

by $0.93

Q4'25

Missed

by $0.95

Q3'25

Missed

by $0.01

Q2'25

Missed

by $0.01

The last earnings report on May 15 showed earnings per share of -97 cents, missing the estimate of -3 cents. With 294.40K shares outstanding, the current market capitalization sits at 15.97M.

View a ticker or compare two or three

Compare

VNRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VNRX